Olmesartan Medoxomil Accord

Olmesartan medoxil, the active ingredient in Olmesartan Medoxil Accord, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is indicated for the management of hypertension in adult patients. GNH USA supplies Olmesartan Medoxil Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxil Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Medoxil Accord is an ARB that lowers blood pressure by blocking the effects of angiotensin II on the vascular system.

- Hypertension: helps achieve target blood pressure and reduces cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: slows progression of kidney damage associated with diabetes.

Common Side Effects: - Dizziness. - Headache. - Fatigue. - Nasal congestion. - Diarrhea. - Upper respiratory tract infection.

Serious or Rare Side Effects: - Angio‑angry  - Hyper‑hyper  - Liver  - Kidney  - Severe hypotension  - Acute pancre 

Olmesartan Medoxil Accord should be used cautiously.

- Renal impairment: dose adjustment may require - Electrolyte  - Pregnancy   - Breast  - Concomitant use  - Store  - Store at  - 

The 

  """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" """